Original InvestigationEditorial CommentCOVID-19 Vaccine Myocarditis∗: Cautious Reassurance in an Era of Dynamic Uncertainty
Editorial Comment
Under an Elsevier user license
open archive
Corresponding Author
Key Words
COVID-19
mRNA vaccine
myocarditis
pericarditis
prognosis
SARS-CoV-2
vaccination
Cited by (0)
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
- ∗
Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of the Journal of the American College of Cardiology or the American College of Cardiology.
© 2022 Published by Elsevier on behalf of the American College of Cardiology Foundation